跳至主要内容
临床试验/NCT00058058
NCT00058058已完成不适用

MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer

American College of Radiology Imaging Network42 个研究点 分布在 3 个国家目标入组 1,007 人开始时间: 2003年2月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,007
试验地点
42
主要终点
MRI Diagnostic Yield of Cancers in the Contralateral Breast

研究概览

简要总结

RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may improve the ability to detect cancer in the unaffected breast of women recently diagnosed with unilateral breast cancer.

PURPOSE: Diagnostic trial to determine the effectiveness of MRI in evaluating the unaffected breast of women recently diagnosed with unilateral breast cancer.

详细描述

OBJECTIVES:

  • Determine the diagnostic yield of magnetic resonance imaging (MRI) in evaluating the contralateral breast of women with a recent unilateral diagnosis of breast cancer and a negative contralateral mammogram and clinical breast exam.
  • Determine the sensitivity, specificity, positive predictive value for both call backs for additional imaging and biopsy recommendations, and receiver operating characteristic curves of MRI in evaluating these patients.
  • Determine the effect of the following patient-related factors: age (50 years old and over vs less than 50 years old), breast parenchymal density (fatty vs non fatty breast), and tumor histology (invasive lobular vs invasive ductal, invasive vs in situ) on the performance of MRI (cancer yield, sensitivity, specificity, and PPV).

OUTLINE: This is a multicenter study.

Patients receive gadopentetate dimeglumine IV and then undergo magnetic resonance imaging of the contralateral breast.

Patients are followed at 12-18 and 24-30 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

MRI Evaluation of Contralateral Breast

Experimental

The cohort is a distinct population of women at high risk for breast carcinoma: women with a recent (within 60 days) personal diagnosis of breast cancer who will have MRI to evaluate the contralateral breast.

干预措施: MRI (Procedure)

结局指标

主要结局

MRI Diagnostic Yield of Cancers in the Contralateral Breast

时间窗: within 90 days of a negative mammogram of the study breast

To assess the diagnostic yield of magnetic resonance imaging (MRI) in evaluating the contralateral breast of women with a recent unilateral diagnosis of breast cancer and a negative contralateral mammogram and clinical breast exam. the "Test" status was defined based on combinations of the following 4 factors: 1. The initial BI-RADs: from the MRI of the contralateral breast 2. The final BI-RADs: determined after all subsequent work-up and follow-up within 365 from the initial MRI (an explicit recommendation for biopsy always resulted in a final BI-RADs of 4). 3. Subsequent work-up includes all procedures resultant from an Initial MRI finding (generally triggered by a BI-RADs 0 or 3) within 365 from the initial MRI 4. Whether or not biopsy procedure (Bx) were performed on the contralateral (Study) breast within 365 from the initial MRI

次要结局

  • MRI Detection of Cancer in the Contralateral Breast for the Estimation of Diagnostic Accuracy(within 90 days of a negative mammogram of the study breast)
  • AUC as a Measure of the Accuracy of MRI for the Detection of Cancer in the Contralateral Breast(within 90 days of a negative mammogram of the study breast)

研究者

申办方类型
Network
责任方
Sponsor

研究点 (42)

Loading locations...

相似试验